Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Carcinoma, Non-Small-Cell Lung 1Advanced/Metastatic Solid Tumors 1

Interventions

Cisplatin 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3pembrolizumab 2Cetuximab 2Biopsy 2utomilumab 1tremelimumab 1motexafin gadolinium 1durvalumab 1antineoplaston AS 2-1 1antineoplaston A10 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiosurgery 1Radiation 1Platinum 1Observation 1Nivolumab 1Ipilimumab 1Immunohistochemistry 1Immunoglobulin G 1Fluorouracil 1Fluorescent Antibody Technique 1Flow Cytometry 1Etoposide 1Electroacupuncture 1Drug Therapy 1Disulfides 1Diagnosis, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Oropharyngeal Neoplasms × utomilumab × Clear all
NCT03258008 2022-12-16

Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡